Global Neurology Academy

Immunologic Effects on Metabolic Syndrome and MS

Immunologic Effects on Metabolic Syndrome and MS
RestartResume
    In this interview, Lawrence Sherman and Dr. Ralf Gold discusses the study, "Immunologic Effects of Metformin and Pioglitazone Treatment on Metaboli...
    • Overview

      In this interview, Lawrence Sherman and Dr. Ralf Gold discusses the study, "Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis," which was led by researchers, Laura Negrotto and Dr. Raul Carrea. They will also discuss the impact of the drugs on clinical biomarkers and MRI, as well as future research on immunologic effects tied to MS.

      This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

    Facebook Comments

    Sign up for the Global Neurology Academy newsletters.
    Comprehensive Neurology Education.

    Better education for a better you.

    * Required
    Optional
    Register

    We’re glad to see you’re enjoying Global Neurology Academy…
    but how about a more personalized experience?

    Register for free